Pictet Asset Management Holding SA Sells 9,330 Shares of Chemed Co. (NYSE:CHE)

Pictet Asset Management Holding SA lowered its holdings in shares of Chemed Co. (NYSE:CHE) by 24.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,541 shares of the company’s stock after selling 9,330 shares during the period. Pictet Asset Management Holding SA owned approximately 0.20% of Chemed worth $15,651,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. UMB Bank n.a. raised its position in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after purchasing an additional 39 shares during the last quarter. Atala Financial Inc purchased a new position in Chemed in the 4th quarter worth about $29,000. CBIZ Investment Advisory Services LLC lifted its stake in Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock valued at $30,000 after acquiring an additional 22 shares during the period. Trust Co. of Vermont purchased a new stake in shares of Chemed during the 4th quarter valued at about $34,000. Finally, Tortoise Investment Management LLC grew its stake in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock worth $41,000 after acquiring an additional 34 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Price Performance

Shares of CHE stock opened at $618.14 on Wednesday. The company has a market cap of $9.05 billion, a price-to-earnings ratio of 31.23, a PEG ratio of 2.15 and a beta of 0.43. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $639.61. The firm has a fifty day moving average price of $576.54 and a 200-day moving average price of $567.29.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date was Monday, February 24th. Chemed’s payout ratio is 10.05%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on CHE shares. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada increased their target price on Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a report on Friday, March 14th.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the sale, the chief executive officer now directly owns 101,679 shares of the company’s stock, valued at approximately $62,566,139.07. This represents a 0.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.